Researchers at the University of Michigan sought to identify the percentage of older adults who may have experienced isolation or loneliness during the COVID-19 pandemic in their National Poll on Healthy Aging.
Considering the impact quarantine has on resources and individual liberty, it is important to evaluate under what conditions individual quarantine can more effectively control COVID-19 than active monitoring.
Although the Centers for Medicare and Medicaid Services had proposed a rule to allow non-physician providers the ability to provide the same services as physicians, more than 120 medical organizations opposed this ruling, and it ultimately was passed with limitations.
The study, which was conducted at Kaiser Permanente Colorado, aimed to compare the longitudinal stability of TSH in patients taking synthetic levothyroxine vs desiccated thyroid products.
A retrospective study was conducted to evaluate the demographic predictors of ADHD in hospitalized children with ASD and the impact of comorbidities on length of stay.
In expanded research, investigators studied the effects of therapeutic and prophylactic anticoagulation treatment in hospitalized patients with COVID-19.
The 2020 American Association of Nurse Practitioners National Conference will be held virtually in place of the meeting that was scheduled for June 2020 in New Orleans, LA.
Researchers assessed data from short-term studies with open-label extensions among adults and adolescents with bipolar depression to assess the impact of lurasidone on treatment-emergent mania.
Recommendations for pharmacotherapy with antipsychotics as both acute and maintenance treatment of schizophrenia were made following a systematic literature review of current clinical practice guidelines.
Post-hoc analyses of pooled data from the randomized, double-blind ASPIRE 1 and ASPIRE II studies were conducted to assess the effect of esketamine in adult patients with major depressive disorder and active suicidal ideation.
Researchers report on the 52-week extension of the ENLIGHTEN-2 study that assessed the long-term safety and efficacy of treatment schizophrenia with olanzapine and samidorphan.
A pooled analysis evaluated reductions in migraine and headache days among patients with chronic migraine and comorbid depression in 2 placebo-controlled, phase 3 trials of fremanezumab.
Depression, a significant cause of disability in the United States, is largely managed by primary care providers; therefore, understanding how these clinicians manage depression is an important step toward identifying opportunities for improvement.
Researchers used data from the National Health and Nutrition Examination Survey 2009-2018 to assess the impact of drug and alcohol use on cardiometabolic disease risk factors.
In order to assess the efficacy and safety of JZP-258, a lower sodium alternative product to sodium oxybate, study authors designed a double-blind, placebo-controlled, randomized withdrawal, multicenter study with an open-label safety extension.
Researchers conducted a study to evaluate the validity of, and satisfaction with, the Cognition KIT DSST mobile app in patients with major depressive disorder.
Researchers conducted an 8-week, open-label, single-arm study and a subsequent 2-stage, sequential, parallel comparison study to assess the use of pimavanserin among patients with Parkinson disease and major depressive disorder.
Clinical trials were conducted to assess the effect brexanolone and zuranolone, neuroactive steroids that are positive allosteric modulators of the gamma-aminobutyric acid receptor, on depression in postpartum women.
Investigators conducted a comprehensive literature search to identify key characteristics that best differentiate between bipolar I disorder and major depressive disorder.
Analysis of the HARMONY trial was conducted to evaluate the prevention of relapse in patients with dementia-related psychosis who have been treated with pimavanserin.
Investigators sought to identify characteristics associated with length of hospital stay in individuals undergoing electroconvulsive therapy for bipolar disorder.
Investigators conducted a randomized clinical trial to assess the safety and efficacy of the investigational stimulant AR19 for the treatment of symptoms of attention-deficit/hyperactivity disorder in adults.
Researchers sought to evaluate the prevalence of pre-existing conditions for adverse events and potential drug-drug interactions related to selected atypical antipsychotics and other non-antidepressant agents among adults with treatment-resistant depression.
Extrapyramidal symptoms that developed in patients with schizophrenia after initiation of treatment with atypical antipsychotic agents were associated with increased healthcare resources and costs.
Research was conducted to assess the impact of initiation of treatment with second-generation antipsychotics and treatment interruptions on weight gain in patients with schizophrenia and bipolar 1 disorder.
ASTHMAXcel Adventures is a gamified, guideline-based, pediatric mobile application that improves asthma control, knowledge, and quality of life, and reduces emergency department visits.
